Literature DB >> 9660482

Reoxygenation injury in a cultured corneal epithelial cell line protected by the uptake of lactoferrin.

S Shimmura1, M Shimoyama, M Hojo, K Urayama, K Tsubota.   

Abstract

PURPOSE: To investigate whether reoxygenation after extended hypoxia causes cellular damage in cultured corneal epithelial cells and to demonstrate the protective effects of lactoferrin.
METHODS: Immortalized human corneal epithelial cells (T-HCECs) were cultured to confluence in 96-well culture plates, subjected to stringent hypoxia (1% O2, 5% CO2, 94% N2 at 37 degrees C) for 24 hours, and returned to normoxic conditions (5% CO2, 95% air at 37 degrees C). Cell viability was observed by 1 microM propidium iodide staining 0, 2, 4, and 6 hours after reoxygenation. Inhibition studies were performed after 2 hours' reoxygenation, using 2 mM iron chelator desferrioxamine and 0.2 mg/ml lactoferrin. Confocal immunocytochemistry for human lactoferrin and western blot analysis for lactoferrin-induced ferritin were performed in cultured T-HCECs to demonstrate the internalization of lactoferrin after application.
RESULTS: After 2 hours, reoxygenation of T-HCECs after hypoxia produced an increase in cell death that was significantly greater than that observed in normoxic control cells or in cells subjected to hypoxia for the same time span without reoxygenation. The addition of desferrioxamine and lactoferrin at the time of reoxygenation significantly attenuated cellular damage. Confocal immunocytochemistry revealed that lactoferrin is taken into the cytoplasm of T-HCECs as early as 30 minutes after application. This was also demonstrated in western blot analysis by the upregulation of intracellular ferritin at 18 hours by the addition of iron-bound lactoferrin but not by iron-free lactoferrin.
CONCLUSION: Reoxygenation is responsible for increased cellular damage after extensive hypoxia, which is attenuated by chelators of free iron in the cytosol, including the major tear protein lactoferrin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660482

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice.

Authors:  Motoko Kawashima; Tetsuya Kawakita; Takaaki Inaba; Naoko Okada; Masataka Ito; Shigeto Shimmura; Mitsuhiro Watanabe; Ken Shinmura; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

2.  Selenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals.

Authors:  Akihiro Higuchi; Hiroyoshi Inoue; Yoshio Kaneko; Erina Oonishi; Kazuo Tsubota
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

3.  Acute hypoxia influences collagen and matrix metalloproteinase expression by human keratoconus cells in vitro.

Authors:  Tina B McKay; Jesper Hjortdal; Shrestha Priyadarsini; Dimitrios Karamichos
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 4.  Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances.

Authors:  Md Sarwar Zahan; Kazi Ahsan Ahmed; Akhi Moni; Alessandra Sinopoli; Hunjoo Ha; Md Jamal Uddin
Journal:  Korean J Physiol Pharmacol       Date:  2022-01-01       Impact factor: 2.016

5.  Selenium compound protects corneal epithelium against oxidative stress.

Authors:  Akihiro Higuchi; Hiroyoshi Inoue; Tetsuya Kawakita; Tadashi Ogishima; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.